搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Schizosaccharomyces pombe Septation protein etd1 (etd1) CSB-YP890838SXV
CSB-EP890838SXV
CSB-BP890838SXV
CSB-MP890838SXV
CSB-EP890838SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Ubiquitin carboxyl-terminal hydrolase 21 (ubp21), partial CSB-YP890839SXV
CSB-EP890839SXV
CSB-BP890839SXV
CSB-MP890839SXV
CSB-EP890839SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Ribosome biogenesis protein nsa2 (nsa2) CSB-YP890840SXV
CSB-EP890840SXV
CSB-BP890840SXV
CSB-MP890840SXV
CSB-EP890840SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Inosine triphosphate pyrophosphatase (SPCC830.10) CSB-YP890841SXV
CSB-EP890841SXV
CSB-BP890841SXV
CSB-MP890841SXV
CSB-EP890841SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Meiotically up-regulated gene 128 protein (mug128) CSB-YP890842SXV
CSB-EP890842SXV
CSB-BP890842SXV
CSB-MP890842SXV
CSB-EP890842SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Translocation protein sec66 (sec66), partial CSB-YP890843SXV
CSB-EP890843SXV
CSB-BP890843SXV
CSB-MP890843SXV
CSB-EP890843SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe 6,7-dimethyl-8-ribityllumazine synthase (rib4) CSB-YP890844SXV
CSB-EP890844SXV
CSB-BP890844SXV
CSB-MP890844SXV
CSB-EP890844SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Cytoplasmic tRNA 2-thiolation protein 2 (ncs2) CSB-YP890845SXV
CSB-EP890845SXV
CSB-BP890845SXV
CSB-MP890845SXV
CSB-EP890845SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized peptidase C18A7.01 (SPBC18A7.01, SPBC4F6.19c) CSB-YP890846SXV
CSB-EP890846SXV
CSB-BP890846SXV
CSB-MP890846SXV
CSB-EP890846SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Peptidyl-prolyl cis-trans isomerase cyp6 (cyp6) CSB-YP890847SXV
CSB-EP890847SXV
CSB-BP890847SXV
CSB-MP890847SXV
CSB-EP890847SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Deoxyribonuclease Tat-D (pi038, SPBC17A3.08) CSB-YP890848SXV
CSB-EP890848SXV
CSB-BP890848SXV
CSB-MP890848SXV
CSB-EP890848SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Ribosome production factor 2 homolog (SPAC926.08c) CSB-YP890849SXV
CSB-EP890849SXV
CSB-BP890849SXV
CSB-MP890849SXV
CSB-EP890849SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C630.12 (SPAC630.12), partial CSB-YP890850SXV1
CSB-EP890850SXV1
CSB-BP890850SXV1
CSB-MP890850SXV1
CSB-EP890850SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe U6 snRNA-associated Sm-like protein LSm6 (lsm6) CSB-YP890851SXV
CSB-EP890851SXV
CSB-BP890851SXV
CSB-MP890851SXV
CSB-EP890851SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Putative alpha,alpha-trehalose-phosphate synthase [UDP-forming] 100 kDa subunit (SPAC22F8.05), partial CSB-YP890852SXV
CSB-EP890852SXV
CSB-BP890852SXV
CSB-MP890852SXV
CSB-EP890852SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe COP9 signalosome complex subunit 7 (csn71) CSB-YP890853SXV
CSB-EP890853SXV
CSB-BP890853SXV
CSB-MP890853SXV
CSB-EP890853SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe OTU domain-containing protein C1952.03 (SPAC1952.03) CSB-YP890854SXV
CSB-EP890854SXV
CSB-BP890854SXV
CSB-MP890854SXV
CSB-EP890854SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C405.02c (SPBC405.02c), partial CSB-YP890855SXV1
CSB-EP890855SXV1
CSB-BP890855SXV1
CSB-MP890855SXV1
CSB-EP890855SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aldehyde reductase 2 CSB-YP890856SKL
CSB-EP890856SKL
CSB-BP890856SKL
CSB-MP890856SKL
CSB-EP890856SKL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Beta-mannosidase (mndA), partial CSB-YP890857DOZ
CSB-EP890857DOZ
CSB-BP890857DOZ
CSB-MP890857DOZ
CSB-EP890857DOZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細(xì)胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>